Glazer WM - Search Results

1

The prediction of chronic persistent versus intermittent tardive dyskinesia. A retrospective follow-up study.

Glazer WM, Morgenstern H, Doucette JT. Glazer WM, et al. Br J Psychiatry. 1991 Jun;158:822-8. doi: 10.1192/bjp.158.6.822. Br J Psychiatry. 1991. PMID: 1678663

2

Positive and negative symptom course in chronic community-based patients. A two-year prospective study.

Quinlan DM, Schuldberg D, Morgenstern H, Glazer W. Quinlan DM, et al. Br J Psychiatry. 1995 May;166(5):634-41. doi: 10.1192/bjp.166.5.634. Br J Psychiatry. 1995. PMID: 7620749

3

Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.

Glazer WM, Morgenstern H, Schooler N, Berkman CS, Moore DC. Glazer WM, et al. Br J Psychiatry. 1990 Oct;157:585-92. doi: 10.1192/bjp.157.4.585. Br J Psychiatry. 1990. PMID: 1983390

4

Platelet monoamine oxidase activity and tardive dyskinesia.

Morgenstern H, Hafez HM, Glazer WM, Giller E Jr, Zahner G. Morgenstern H, et al. Among authors: glazer wm. Psychiatry Res. 1988 Aug;25(2):163-71. doi: 10.1016/0165-1781(88)90047-9. Psychiatry Res. 1988. PMID: 2902653

5

Predictors of occurrence, severity, and course of tardive dyskinesia in an outpatient population.

Glazer WM, Morgenstern H. Glazer WM, et al. J Clin Psychopharmacol. 1988 Aug;8(4 Suppl):10S-16S. J Clin Psychopharmacol. 1988. PMID: 3065363 Review.

6

Heterogeneity of tardive dyskinesia. A multivariate analysis.

Glazer WM, Morgenstern H, Niedzwiecki D, Hughes J. Glazer WM, et al. Br J Psychiatry. 1988 Feb;152:253-9. doi: 10.1192/bjp.152.2.253. Br J Psychiatry. 1988. PMID: 3262396

7

Race and tardive dyskinesia among outpatients at a CMHC.

Glazer WM, Morgenstern H, Doucette J. Glazer WM, et al. Hosp Community Psychiatry. 1994 Jan;45(1):38-42. doi: 10.1176/ps.45.1.38. Hosp Community Psychiatry. 1994. PMID: 7907310

8

Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications.

Glazer WM, Morgenstern H, Doucette JT. Glazer WM, et al. J Clin Psychiatry. 1993 Apr;54(4):133-9. J Clin Psychiatry. 1993. PMID: 8098030

9

Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.

Morgenstern H, Glazer WM. Morgenstern H, et al. Among authors: glazer wm. Arch Gen Psychiatry. 1993 Sep;50(9):723-33. doi: 10.1001/archpsyc.1993.01820210057007. Arch Gen Psychiatry. 1993. PMID: 8102845

10

Handedness and the risk of tardive dyskinesia.

Morgenstern H, Glazer WM, Doucette JT. Morgenstern H, et al. Among authors: glazer wm. Biol Psychiatry. 1996 Jul 1;40(1):35-42. doi: 10.1016/0006-3223(95)00357-6. Biol Psychiatry. 1996. PMID: 8780853 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page